• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1999 - 2012年美国儿童中的耐碳青霉烯类肠杆菌科细菌

Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.

作者信息

Logan Latania K, Renschler John P, Gandra Sumanth, Weinstein Robert A, Laxminarayan Ramanan

出版信息

Emerg Infect Dis. 2015 Nov;21(11):2014-21. doi: 10.3201/eid2111.150548.

DOI:10.3201/eid2111.150548
PMID:26486124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4622248/
Abstract

The prevalence of carbapenem-resistant Enterobacteriaceae (CRE) infections is increasing in the United States. However, few studies have addressed their epidemiology in children. To phenotypically identify CRE isolates cultured from patients 1-17 years of age, we used antimicrobial susceptibilities of Enterobacteriaceae reported to 300 laboratories participating in The Surveillance Network-USA database during January 1999-July 2012. Of 316,253 isolates analyzed, 266 (0.08%) were identified as CRE. CRE infection rate increases were highest for Enterobacter species, blood culture isolates, and isolates from intensive care units, increasing from 0.0% in 1999-2000 to 5.2%, 4.5%, and 3.2%, respectively, in 2011-2012. CRE occurrence in children is increasing but remains low and is less common than that for extended-spectrum β-lactamase-producing Enterobacteriaceae. The molecular characterization of CRE isolates from children and clinical epidemiology of infection are essential for development of effective prevention strategies.

摘要

在美国,耐碳青霉烯类肠杆菌科细菌(CRE)感染的患病率正在上升。然而,很少有研究涉及它们在儿童中的流行病学情况。为了从表型上鉴定从1至17岁患者中培养出的CRE分离株,我们利用了1999年1月至2012年7月期间向参与美国监测网络数据库的300个实验室报告的肠杆菌科细菌的抗菌药敏数据。在分析的316,253株分离株中,266株(0.08%)被鉴定为CRE。肠杆菌属、血培养分离株以及重症监护病房分离株的CRE感染率上升幅度最大,分别从1999 - 2000年的0.0%增至2011 - 2012年的5.2%、4.5%和3.2%。儿童中CRE的发生率正在上升,但仍然很低,且比产超广谱β-内酰胺酶的肠杆菌科细菌少见。对儿童CRE分离株进行分子特征分析以及感染的临床流行病学研究对于制定有效的预防策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfde/4622248/33bf082d2657/15-0548-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfde/4622248/b7582723a00a/15-0548-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfde/4622248/47def8cf8631/15-0548-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfde/4622248/33bf082d2657/15-0548-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfde/4622248/b7582723a00a/15-0548-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfde/4622248/47def8cf8631/15-0548-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfde/4622248/33bf082d2657/15-0548-F3.jpg

相似文献

1
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.1999 - 2012年美国儿童中的耐碳青霉烯类肠杆菌科细菌
Emerg Infect Dis. 2015 Nov;21(11):2014-21. doi: 10.3201/eid2111.150548.
2
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.泰国一家大学医院耐碳青霉烯类肠杆菌科细菌的基因特征及耐碳青霉烯类肺炎克雷伯菌ST340的传播
PLoS One. 2015 Sep 25;10(9):e0139116. doi: 10.1371/journal.pone.0139116. eCollection 2015.
3
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).耐碳青霉烯类肠杆菌科细菌(CRE)中异质性耐药机制对感染控制的影响
Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4.
4
Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.儿童耐碳青霉烯肠杆菌科定植或感染的危险因素的多中心研究。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01440-17. Print 2017 Dec.
5
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.通过严格的接触预防措施成功控制耐碳青霉烯类肠杆菌科细菌,无需主动监测。
Am J Infect Control. 2014 Dec;42(12):1270-3. doi: 10.1016/j.ajic.2014.09.004. Epub 2014 Nov 25.
6
Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.2000 年至 2009 年美国住院肺炎和血流感染患者标本中产超广谱β-内酰胺酶肠杆菌科和耐碳青霉烯类铜绿假单胞菌的流行情况。
J Hosp Med. 2013 Oct;8(10):559-63. doi: 10.1002/jhm.2080. Epub 2013 Sep 10.
7
Carbapenem-resistant enterobacteriaceae: an emerging problem in children.碳青霉烯类耐药肠杆菌科细菌:儿童中出现的一个新问题。
Clin Infect Dis. 2012 Sep;55(6):852-9. doi: 10.1093/cid/cis543. Epub 2012 Jun 14.
8
Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.与耐碳青霉烯类肠杆菌科细菌粪便携带率和发病率相关的因素:墨西哥一家三级护理医院的队列研究。
PLoS One. 2015 Oct 2;10(10):e0139883. doi: 10.1371/journal.pone.0139883. eCollection 2015.
9
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.耐碳青霉烯类肠杆菌科细菌:流行病学与预防。
Clin Infect Dis. 2011 Jul 1;53(1):60-7. doi: 10.1093/cid/cir202.
10
Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.英国一家儿童医院中产碳青霉烯类耐药肠杆菌科细菌的出现
J Hosp Infect. 2013 Aug;84(4):300-4. doi: 10.1016/j.jhin.2013.05.003. Epub 2013 Jul 5.

引用本文的文献

1
Fecal carriage and molecular characterization of carbapenem-resistant from hospitalized children in a tertiary hospital of Shandong, China.中国山东某三级医院住院儿童耐碳青霉烯类细菌的粪便携带情况及分子特征分析
Front Microbiol. 2025 Feb 18;16:1542207. doi: 10.3389/fmicb.2025.1542207. eCollection 2025.
2
Phenotypic and molecular methods of carbapenemase detection: Can we break the chain and preserve the carbapenems?碳青霉烯酶检测的表型和分子方法:我们能否阻断传播链并保留碳青霉烯类药物?
Med J Armed Forces India. 2024 Nov-Dec;80(6):657-666. doi: 10.1016/j.mjafi.2023.05.008. Epub 2023 Jul 18.
3
Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.

本文引用的文献

1
Extended-Spectrum β-Lactamase-Producing and Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Children: Trends in the United States, 1999-2011.美国1999 - 2011年儿童中产超广谱β-内酰胺酶及对第三代头孢菌素耐药的肠杆菌科细菌:趋势分析
J Pediatric Infect Dis Soc. 2014 Dec;3(4):320-8. doi: 10.1093/jpids/piu010. Epub 2014 Mar 19.
2
Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital.美国一家儿科医院爆发产KPC-3型碳青霉烯类耐药肺炎克雷伯菌疫情。
J Pediatric Infect Dis Soc. 2015 Dec;4(4):330-8. doi: 10.1093/jpids/piu080. Epub 2014 Nov 3.
3
Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.
碳青霉烯类耐药肠杆菌科细菌血流感染患儿的临床结局及治疗方式的影响:一项来自三级大学医院的回顾性队列研究
J Antimicrob Chemother. 2025 Jan 3;80(1):147-153. doi: 10.1093/jac/dkae387.
4
Ceftazidime-Avibactam Use in a Case Series of Difficult-to-Treat or Recurrent Infections in Pediatric Patients with Complex Chronic Conditions: Effectiveness and Absence of Resistance Development.头孢他啶-阿维巴坦在患有复杂慢性病的儿科患者难治性或复发性感染病例系列中的应用:有效性及未出现耐药性发展情况
Antibiotics (Basel). 2024 Jun 27;13(7):598. doi: 10.3390/antibiotics13070598.
5
Epidemiology of Citrobacter spp. infections among hospitalized patients: a systematic review and meta-analysis.住院患者中柠檬酸杆菌属感染的流行病学:系统评价和荟萃分析。
BMC Infect Dis. 2024 Jul 2;24(1):662. doi: 10.1186/s12879-024-09575-8.
6
Carbapenem-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.2016-2020 年美国儿童中产碳青霉烯酶和产超广谱β-内酰胺酶的肠杆菌科细菌
Emerg Infect Dis. 2024 Jun;30(6):1104-1114. doi: 10.3201/eid3006.231734.
7
Carbapenem-resistant in Children at 18 US Health Care System Study Sites: Clinical and Molecular Epidemiology From a Prospective Multicenter Cohort Study.美国18个医疗保健系统研究地点儿童耐碳青霉烯类情况:一项前瞻性多中心队列研究的临床和分子流行病学
Open Forum Infect Dis. 2024 Jan 8;11(2):ofad688. doi: 10.1093/ofid/ofad688. eCollection 2024 Feb.
8
The role of the plasmid-mediated fluoroquinolone resistance genes as resistance mechanisms in pediatric infections due to Enterobacterales.质粒介导的氟喹诺酮类耐药基因在肠杆菌科引起的儿科感染中的耐药机制作用。
Front Cell Infect Microbiol. 2023 Oct 9;13:1249505. doi: 10.3389/fcimb.2023.1249505. eCollection 2023.
9
Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study.头孢他啶-阿维巴坦用于儿童疑似或确诊耐碳青霉烯类微生物感染的回顾性研究。
Infect Drug Resist. 2023 Sep 5;16:5815-5824. doi: 10.2147/IDR.S426326. eCollection 2023.
10
Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort study.儿童癌症或造血干细胞移植后血流感染中的肠杆菌科碳青霉烯耐药:一项回顾性队列研究。
J Antimicrob Chemother. 2023 Oct 3;78(10):2462-2470. doi: 10.1093/jac/dkad255.
产超广谱β-内酰胺酶肠杆菌科细菌在儿童中的情况:老对手,新威胁
Clin Infect Dis. 2015 May 1;60(9):1389-97. doi: 10.1093/cid/civ020. Epub 2015 Jan 16.
4
Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.由产超广谱头孢菌素酶肠杆菌科细菌引起的儿科感染及肠道定植
Antimicrob Agents Chemother. 2014 Jul;58(7):3997-4004. doi: 10.1128/AAC.02558-14. Epub 2014 May 5.
5
Treatment of multidrug-resistant Gram-negative infections in children.儿童耐多药革兰氏阴性菌感染的治疗。
Clin Infect Dis. 2014 May;58(10):1439-48. doi: 10.1093/cid/ciu069. Epub 2014 Feb 5.
6
Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy.意大利一新生儿重症监护病房产碳青霉烯酶肺炎克雷伯菌碳青霉烯酶 258 型定植爆发的成功控制。
J Hosp Infect. 2013 Nov;85(3):233-6. doi: 10.1016/j.jhin.2013.08.004. Epub 2013 Sep 8.
7
The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.产碳青霉烯酶肠杆菌科细菌的地区流行病学中,长期急性护理医院的重要性。
Clin Infect Dis. 2013 Nov;57(9):1246-52. doi: 10.1093/cid/cit500. Epub 2013 Aug 14.
8
Multilocus sequence typing (MLST) for characterization of Enterobacter cloacae.肠杆菌科的多位点序列分型(MLST)用于特征描述。
PLoS One. 2013 Jun 11;8(6):e66358. doi: 10.1371/journal.pone.0066358. Print 2013.
9
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).26 家美国医院采集的肠杆菌科菌血症分离株中β-内酰胺酶编码基因的流行率:SENTRY 抗菌药物监测计划(2010 年)的报告。
Antimicrob Agents Chemother. 2013 Jul;57(7):3012-20. doi: 10.1128/AAC.02252-12. Epub 2013 Apr 15.
10
Vital signs: carbapenem-resistant Enterobacteriaceae.生命体征:耐碳青霉烯肠杆菌科。
MMWR Morb Mortal Wkly Rep. 2013 Mar 8;62(9):165-70.